Standout Papers

FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma 2007 2026 2013 2019 1.1k
  1. FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma (2007)
    Bhupinder Mann, John R. Johnson et al. The Oncologist

Immediate Impact

14 by Nobel laureates 15 from Science/Nature 54 standout
Sub-graph 1 of 22

Citing Papers

Cross-Electrophile Coupling: Principles, Methods, and Applications in Synthesis
2024 Standout
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
2022 Standout
7 intermediate papers

Works of John R. Johnson being referenced

Accelerated Approval of Oncology Products: The Food and Drug Administration Experience
2011
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
2002
and 3 more

Author Peers

Author Last Decade Papers Cites
John R. Johnson 1555 3098 2470 2207 254 12.3k
John W. McDonald 791 1305 3291 3502 262 15.0k
John P. Lynch 1408 3136 374 1288 215 9.0k
Markus Ritter 1091 1375 705 6418 203 13.4k
George D. Wilson 347 934 642 4073 346 10.6k
William P. Weber 906 1129 695 2118 413 9.8k
Yutaka Ueda 3353 1072 413 1873 951 20.7k
Wolfgang Weber 589 3542 1795 4509 690 31.0k
Jun Liu 404 4000 538 3981 622 12.8k
Hugh S. Taylor 346 1157 813 4377 477 24.1k
Michael Hawkins 431 631 671 3234 131 10.8k

All Works

Loading papers...

Rankless by CCL
2026